| A Multiple Ascending Dose Study With AZD9164 Given for 13 Days in Healthy Male and Female Subjects and in Patients With Chronic Obstructive Pulmonary Disease (NCT01016951) | AstraZeneca | 2009-12-01 |
| RAD001, Cisplatin and Concurrent Radiation for Locally Advanced, Inoperable Head and Neck Cancer (NCT01057277) | howard safran | 2009-12-01 |
| A Study of Single Doses of RO4998452 in Patients With Type 2 Diabetes (NCT01044017) | Hoffmann-La Roche | 2009-12-01 |
| Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies (NCT01041235) | Azaya Therapeutics, Inc. | 2009-12-01 |
| Study of Weekly LOC-paclitaxel Injection for Melanoma (NCT01039844) | M.D. Anderson Cancer Center | 2009-12-01 |
| Pharmacokinetics and Safety of Cefazolin 2g in DUPLEX (NCT01121354) | B. Braun Medical Inc. | 2009-12-01 |
| A Study With RO5095932 in Patients With Type 2 Diabetes on Stable Metformin Therapy. (NCT01017302) | Hoffmann-La Roche | 2009-12-01 |
| To Assess the Effect of Rifampicin on the Pharmacokinetics of Eribulin Mesylate in Participants With Advanced Solid Tumors (NCT03002493) | Eisai Limited | 2009-12-01 |
| Safety and Efficacy Study of Intramuscular Uricase-PEG 20 (NCT01038947) | EnzymeRx | 2009-12-01 |
| Safety and Efficacy of Sodium Nitrite in Sickle Cell Disease (NCT01033227) | Children's Hospital Los Angeles | 2009-12-01 |
| A Dose Ranging Study of Delayed Release Beclomethasone for Prevention of Acute Enteritis in Patients With Rectal Cancer (NCT01073384) | Soligenix | 2009-12-01 |
| Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) in Healthy Volunteers (NCT00934453) | Massachusetts General Hospital | 2009-12-01 |
| Safety and Efficacy of TXA127 and Neupogen to Increase Peripheral Blood Stem Cells (PBSCs) (NCT01543971) | Tarix Pharmaceuticals | 2009-12-01 |
| First In Human Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-04427429 Administered Intravenously To Healthy Adult Volunteers (NCT01011296) | Pfizer | 2009-12-01 |
| A Pilot Study Investigating the Clinical Use of Tissue Engineered Vascular Grafts in Congenital Heart Surgery (NCT01034007) | Christopher Breuer | 2009-12-01 |
| Safety and Pharmacokinetic Study of Oral ON 01910.Na in Patients With Myelodysplastic Syndrome (NCT01048619) | Traws Pharma, Inc. | 2009-12-01 |
| Safety Study of the Monoclonal Antibody Teplizumab (MGA031) in Subjects With Moderate or More Severe Psoriasis (NCT00954915) | MacroGenics | 2009-12-01 |
| Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial) (NCT01023477) | Inova Health Care Services | 2009-12-01 |
| Everolimus Dose Finding Study for Stage IV or Recurrent Cervical Cancer (NCT00967928) | Accelerated Community Oncology Research Network | 2009-12-01 |
| A Safety and Tolerability Study of Administration of PSD502 (NCT01183208) | Plethora Solutions Ltd | 2009-12-01 |
| Study of Plerixafor Combined With Cytarabine and Daunorubicin in Patients With Newly Diagnosed Acute Myeloid Leukemia (NCT00990054) | Genzyme, a Sanofi Company | 2009-12-01 |
| Safety, Tolerability and Pharmacokinetics of Multiple Doses of ZGN-433 in Obese Female Volunteers (NCT01028261) | Zafgen, Inc. | 2009-12-01 |
| Treatment With Ribavirin for Patients With Metastatic Breast Cancer (NCT01056757) | Jewish General Hospital | 2009-12-01 |
| Combination Anticancer Therapy of Paclitaxel and Everolimus for Relapsed or Refractory Small Cell Lung Cancer (NCT01079481) | Samsung Medical Center | 2009-12-01 |
| Hepatic Impaired Subjects Compared to Healthy Subjects Receiving Multi-dose BMS-650032 (NCT01019070) | Bristol-Myers Squibb | 2009-12-01 |
| A Pharmacokinetic Study of RO5185426 in Combination With a Drug Cocktail in Patients With Metastatic Melanoma (NCT01001299) | Hoffmann-La Roche | 2009-11-30 |
| First-in-Man, Dose-escalation Trial of C-met Kinase Inhibitor MSC2156119J in Subjects With Advanced Solid Tumors (NCT01014936) | EMD Serono | 2009-11-30 |
| Trial of Gemcitabine With or Without MSC1936369B in Pancreatic Cancer (NCT01016483) | EMD Serono | 2009-11-30 |
| Avandamet Bioequivalence Study Brazil - Fed Administration (NCT01332071) | GlaxoSmithKline | 2009-11-24 |
| A Combination Therapy Study of MK-2206 and AZD6244 in Participants With Advanced Solid Tumors (MK-2206-010) (NCT01021748) | Merck Sharp & Dohme LLC | 2009-11-23 |
| A Study to Compare the Blood Levels of Albaconazole in Healthy Subjects Who Have Received a Single Dose of 400 mg Albaconazole as a Tablet Versus Albaconazole as a Capsule (NCT01039883) | Stiefel, a GSK Company | 2009-11-23 |
| First Time in Human Study (NCT01031186) | GlaxoSmithKline | 2009-11-23 |
| BAY80-6946 Open Label, Phase I Study in Patients With Advanced Cancer (NCT00962611) | Bayer | 2009-11-19 |
| A Single Dose Study of MK-8266 (MK-8266-001) (NCT01025791) | Merck Sharp & Dohme LLC | 2009-11-18 |
| Single and Multiple Oral Administration Study of ASP015K in Healthy Nonelderly Volunteers (NCT01225224) | Astellas Pharma Inc | 2009-11-18 |
| A Safety and Dose Ranging Study of Idursulfase (Intrathecal) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Hunter Syndrome Who Have Central Nervous System Involvement and Are Receiving Treatment With Elaprase® (NCT00920647) | Shire | 2009-11-18 |
| An Open-Label Pharmacodynamic Study of Bevacivumab and Pazopanib in Renal Cell Carcinoma (NCT00992121) | GlaxoSmithKline | 2009-11-18 |
| Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma (NCT01008917) | University of California, San Francisco | 2009-11-17 |
| A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib (NCT00996762) | GlaxoSmithKline | 2009-11-12 |
| Lenalidomide Therapy After Chemotherapy & Stem Cell Transplant in Treating Chemotherapy Resistan Non-Hodgkin Lymphoma (NCT01035463) | University of Nebraska | 2009-11-12 |
| Alcohol Interaction Study (NCT01181908) | GlaxoSmithKline | 2009-11-11 |
| A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006) (NCT00960063) | Merck Sharp & Dohme LLC | 2009-11-11 |
| A Phase I Study of Intravenous Recombinant Human IL-15 in Adults With Refractory Metastatic Malignant Melanoma and Metastatic Renal Cell Cancer (NCT01021059) | National Cancer Institute (NCI) | 2009-11-10 |
| Single Dose Escalation Study of P1101 in Healthy Adult Male Subjects (NCT05129644) | PharmaEssentia | 2009-11-07 |
| A Study of ASP1941 in Japanese Patients With Type 2 Diabetes Mellitus (NCT01023945) | Astellas Pharma Inc | 2009-11-07 |
| A Study to Evaluate the Effects of Single Doses of MK-1064 and MK-6096 on Polysomnography (PSG) (MK-1064-003) (NCT02549027) | Merck Sharp & Dohme LLC | 2009-11-06 |
| Phase I Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of GSK2256098 in Healthy Volunteers (NCT00996671) | GlaxoSmithKline | 2009-11-06 |
| Effect of Food and Calcium on Pharmacokinetics of a Single Dose of S-888711 in Healthy Adult Volunteers (NCT03897413) | Shionogi | 2009-11-06 |
| Safety, Pharmacokinetics (PK) and Tolerability Study of a Novel Drug for Treatment of Bacterial Infections (NCT01015014) | Pfizer | 2009-11-05 |
| Repeat Dose Study of Controlled-Release Paroxetine Tablets and Immediate-Release Paroxetine Tablets in Healthy Japanese Male Subjects (NCT01000857) | GlaxoSmithKline | 2009-11-05 |
| Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer (NCT01012817) | National Cancer Institute (NCI) | 2009-11-03 |
| A Multiple Ascending Dose Study of the mTOR Inhibitor (RAD001) in Combination With R1507 in Patients With Advanced Solid Tumors (NCT00985374) | Hoffmann-La Roche | 2009-11-01 |
| Safety Study of BMS-816336 in Healthy Male Subjects (NCT00979368) | Bristol-Myers Squibb | 2009-11-01 |
| Study of ABT-263 When Administered in Combination With Either Fludarabine/Cyclophosphamide/Rituximab or Bendamustine/Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia (NCT00868413) | AbbVie (prior sponsor, Abbott) | 2009-11-01 |
| Interaction Between Duloxetine and 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) (NCT00990067) | University Hospital, Basel, Switzerland | 2009-11-01 |
| Individually Based Psychosocial Rehabilitation for Older People With Serious Mental Illness (SMI) (NCT00817154) | Dartmouth-Hitchcock Medical Center | 2009-11-01 |
| Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of YH4808 After Oral Administration in Healthy Male Subjects (NCT01007019) | Yuhan Corporation | 2009-11-01 |
| Safety, Tolerability and Pharmacokinetics of Cobimetinib in Combination With Pictilisib in Patients With Locally Advanced or Metastatic Solid Tumors (NCT00996892) | Genentech, Inc. | 2009-11-01 |
| Clinical Study to Investigate the Safety and Pharmacokinetics of Udenafil Tablet in Renal Impaired Male Patients (NCT01231997) | Asan Medical Center | 2009-11-01 |
| Effect of Netazepide on Omeprazole-induced Changes in Chromogranin A and Gastrin (NCT02620696) | Trio Medicines Ltd. | 2009-11-01 |
| Effects of Milnacipran on Widespread Mechanical and Thermal Hyperalgesia of Fibromyalgia Patients (NCT01294059) | University of Florida | 2009-11-01 |
| Aging and Estrogen on Cortical Function (NCT01268046) | Massachusetts General Hospital | 2009-11-01 |
| Panobinostat (LBH589) Plus Everolimus (RAD001) in Patients With Relapsed and Refractory Lymphoma (NCT00967044) | M.D. Anderson Cancer Center | 2009-11-01 |
| Effect of Food and Antacid on BIIB021 With Advanced Solid Tumors (NCT01017198) | Biogen | 2009-11-01 |
| Targeted, Dose-Escalation Busulfan-Etoposide as Prep Regimen (NCT01048827) | University of California, San Francisco | 2009-11-01 |
| A Pharmacokinetic Study to Investigate the Effect of Food on the Pharmacokinetics of YM150 (NCT01118559) | Astellas Pharma Inc | 2009-11-01 |
| BIIB014 Effects on the Pharmacokinetics (PK) of Rosiglitazone, Warfarin, and Midazolam (NCT01017666) | Biogen | 2009-11-01 |
| Examining the Role of Transrectal High Intensity Focused Ultrasound (HIFU) in Rectal Pelvic Cancer (NCT01097239) | Imperial College London | 2009-11-01 |
| Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA) (NCT00977301) | Radboud University Medical Center | 2009-11-01 |
| A Multiple Use Tolerability Study of a Breathe Right Nasal Strip Prototype (NCT01495494) | GlaxoSmithKline | 2009-11-01 |
| A Low Cost Virtual Reality System for Home Based Rehabilitation of the Upper Limb Following Stroke (NCT02637791) | University of Nottingham | 2009-11-01 |
| Does Visceral Manipulation Works in Treating Functional Dyspepsia? (NCT01021475) | International College of Osteopathic Medicine | 2009-11-01 |
| A Study to Characterize the Effect on the Pharmacokinetics of ASP1941 and Pioglitazone Hydrochloride When Given Together to Healthy Subjects (NCT01088919) | Astellas Pharma Inc | 2009-11-01 |
| Safety and Tolerability Study Evaluating ACR325 in Parkinson's Disease Patients (NCT01023282) | NeuroSearch A/S | 2009-11-01 |
| Evaluation of AN777 on Elderly Subjects During Bed Rest and Recovery (NCT00945581) | Abbott Nutrition | 2009-11-01 |
| Bioavailability Study of Fixed Dose Combination (FDC) Formulations of Dapagliflozin and Metformin XR Versus Individual Component Coadministered to Healthy Subjects in a Fasted State (NCT01002807) | AstraZeneca | 2009-11-01 |
| Safety Study of Farletuzumab, Carboplatin and Pegylated Liposomal Doxorubicin (PLD) to Treat Platinum-sensitive Ovarian Cancer (NCT01004380) | Morphotek | 2009-11-01 |
| GLPG0259 Solid Formulation Bioavailability and Food Effect (NCT01024517) | Lakefront Biotherapeutics NV | 2009-11-01 |
| Delayed Versus Early Enoxaparin Prophylaxis After Traumatic Brain Injury (TBI) (NCT01014403) | University of Texas Southwestern Medical Center | 2009-11-01 |
| Resveratrol for Improved Performance in the Elderly (NCT01126229) | University of Florida | 2009-11-01 |
| Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin/1000 mg Metformin XR (Manufactured in Mt Vernon, IN) Relative to 5 mg of Onglyza and 2 × 500 mg Glucophage XR (NCT01192152) | AstraZeneca | 2009-11-01 |
| Ascending Dose Study of the Safety and Tolerability of REGN727(SAR236553) in Healthy Volunteers (NCT01026597) | Regeneron Pharmaceuticals | 2009-11-01 |
| Safety of and Immune Response to the PENNVAX-B DNA Vaccine With and Without IL-12 in HIV-uninfected Adults (NCT00991354) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-11-01 |
| A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas (NCT00909402) | Bristol-Myers Squibb | 2009-11-01 |
| Dose Escalation Safety Study of TL32711 in Adults With Refractory Solid Tumors or Lymphoma (NCT00993239) | TetraLogic Pharmaceuticals | 2009-11-01 |
| Investigation of the Safety of an HIV-1 Vaccine Given Intra-muscularly and Intra-nasally to Healthy Female Subjects (NCT01084343) | Mymetics Corporation | 2009-11-01 |
| PankoMab-GEX™: Phase 1 Dose Escalation Study (NCT01222624) | Glycotope GmbH | 2009-11-01 |
| Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes (NCT00943501) | Novo Nordisk A/S | 2009-11-01 |
| Phase I Study to Determine the Maximum Tolerated Dose and to Assess the Safety and Pharmacokinetic Profile of HM781-36B in Patients With Advanced Solid Tumors (NCT01455571) | Hanmi Pharmaceutical Company Limited | 2009-11-01 |
| RO4929097 and Vismodegib in Treating Patients With Breast Cancer That is Metastatic or Cannot Be Removed By Surgery (NCT01071564) | National Cancer Institute (NCI) | 2009-11-01 |
| Allogenic Immunotherapy Based on Natural Killer (NK) Cell Adoptive Transfer in Metastatic Gastrointestinal Carcinoma Treated With Cetuximab (NCT02845999) | Centre Hospitalier Universitaire de Besancon | 2009-11-01 |
| An Expanded Safety Study of Dapivirine Gel 4759 in Africa (NCT00917891) | International Partnership for Microbicides, Inc. | 2009-11-01 |
| Safety of and Immune Response to Recombinant Live Attenuated Parainfluenza Type 3 Virus Vaccine in Healthy Infants and Children (NCT01021397) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-11-01 |
| A Study of IMC-A12 in Advanced Solid Tumors (NCT01007032) | Eli Lilly and Company | 2009-11-01 |
| An Open-label, Single-dose, Three Period Study to Determine the Pharmacokinetic Parameters of Hexaminolevulinate (HAL) Hydrochloride After Vaginal, Enema and Intravenous Administration of Healthy Female Volunteers (NCT01050309) | Photocure | 2009-11-01 |
| Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1/2-uninfected Mothers (NCT00982579) | Medical Research Council | 2009-11-01 |
| Durability of Hypertonic Saline for Enhancing Mucociliary Clearance in Cystic Fibrosis (NCT01094704) | University of North Carolina, Chapel Hill | 2009-11-01 |
| Study of the Safety and Tolerability of ALTH12 Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis (NCT01020708) | Altheus Therapeutics, Inc. | 2009-11-01 |
| Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin XR Tablet (Manufactured in Mt Vernon, IN) Relative to 5 mg Saxagliptin Tablet and 500 mg Metformin XR Tablet (Manufactured in Evansville, IN) (NCT01192139) | AstraZeneca | 2009-11-01 |
| Tolerability and Potential ECG Effects After a Single Oral Dose of Pentoxyverine Citrate in Healthy Male and Female Volunteers (NCT02183649) | Boehringer Ingelheim | 2009-11-01 |